Unvaccinated adults are nearly six times more likely to test positive for COVID-19 and 14 times more likely to die from the virus compared to vaccinated individuals, new CDC data shows.

Pregnant women who contract COVID-19 may be at an increased risk for stillbirth compared to women without the infection, a Nov. 19 CDC report found.

Before COVID-19 booster shots were authorized for all adults, the U.S. government had already recommended boosters for Americans with certain high-risk conditions, including mental health conditions. The decision came after numerous studies linked mental health disorders to a higher COVID-19 risk and more severe outcomes, NPR reported Nov. 22.

SARS-CoV-2, the virus that causes COVID-19, can sometimes trigger several post-viral syndromes, or diseases occurring after infection, NPR reported Nov. 18.

Loss of taste or smell are defining symptoms of COVID-19, and a new study published Nov. 18 in JAMA Otolaryngology estimates up to 1.6 million people in the U.S. may experience chronic olfactory problems after their infection.  

Medically complex and critically ill patients now makes up 10% of the overall Medicare population, translating into four million individuals around the nation. This rapidly growing population continues to consume a disproportionate amount of acute healthcare resources and has a significantly higher-than-average likelihood of hospital admissions and readmissions.

A CDC analysis published Nov. 18 predicts that when the nationwide intensive care unit bed capacity hits or exceeds 75 percent, thousands of additional excess deaths occur over the following two weeks. 

A new study from Children's National Hospital in Washington, D.C., found that patients with multisystem inflammatory syndrome in children — a rare but serious immune response linked to COVID-19 — had more severe illness during the second wave of patients compared to the first wave. 

Cancer patients and other people taking immune-suppressing medications do not have an overall higher risk of dying from COVID-19, according to a study involving more than 200,000 hospitalized COVID-19 patients. 

As the U.S. enters its regular flu season, there's still a lot unknown about coinfection of flu and SARS-CoV-2 viruses. 

People taking certain antidepressants, particularly fluoxetine, may have a lower death risk from COVID-19, according to research published Nov. 15 in JAMA Network Open.

Medical understanding of pulmonary arterial hypertension (PAH) has come a long way in the last 20 years.1,2 Today, the medical community has a much clearer picture of the pathophysiology of this disease.1

In 2019, three-fourths of the country's 201,092 sepsis-related deaths were among people aged 65 and older, according to a report from the CDC's National Center for Health Statistics published Nov. 10. 

The Hospital Association of Pennsylvania announced Nov. 10 17 systems across the state as 2021 Hospital Association of Pennsylvania Excellence in Patient Safety Program honorees.

People with certain sleep disorders face a 31 percent increased risk for hospitalization and mortality from COVID-19, according to research published Nov. 10 in JAMA Network Open.

People with diabetes, chronic lung disease or chronic kidney disease may be at increased risk for breakthrough infections compared to the general population, according to Nov. 9 research from the health system-led data analytics startup Truveta.

The U.S. lacks a universally accepted set of recommendations for when organs can safely be recovered from COVID-19-positive donors, The New York Times reported Nov. 8. 

New HHS program 1st to link data from mothers and newborns to improve outcomes, reduce disparities 

People with a specific version of a gene known as LTZFL1 may be at increased risk of respiratory failure from COVID-19, according to research published Nov. 4 in Nature. 

A solid foundation of research has shown that men are more likely to die of COVID-19 than women, but the reason for this disparity is still unknown.